These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8289185

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
    Kehne JH, Kane JM, Miller FP, Ketteler HJ, Braun DL, Senyah Y, Chaney SF, Abdallah A, Dudley MW, Ogden AM.
    Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
    [Abstract] [Full Text] [Related]

  • 3. The enhancement of muscimol-stimulated 36C1 influx by the antispastic 5-aryl-3-(alkylsulfonyl)-4H-1,2,4-triazole (MDL 27,531) in rat brain membrane vesicles.
    Miller JA, Braun D, Chmielewski PA, Kane JM.
    Neurosci Lett; 1995 Dec 08; 201(2):183-7. PubMed ID: 8848248
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolines.
    Chen J, Sun XY, Chai KY, Lee JS, Song MS, Quan ZS.
    Bioorg Med Chem; 2007 Nov 01; 15(21):6775-81. PubMed ID: 17761423
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and pharmacological evaluation of novel 1,2,4-triazol-3-amine derivatives as potential agonists of GABAA subtype receptors with anticonvulsant and hypnotic effects.
    Jahani R, Reza Abtahi S, Nematpour M, Fasihi Dastjerdi H, Chamanara M, Hami Z, Paknejad B.
    Bioorg Chem; 2020 Nov 01; 104():104212. PubMed ID: 32916390
    [Abstract] [Full Text] [Related]

  • 7. Development of new chiral 1,2,4-triazole-3-thiones and 1,3,4-thiadiazoles with promising in vivo anticonvulsant activity targeting GABAergic system and voltage-gated sodium channels (VGSCs).
    Karaküçük-İyidoğan A, Başaran E, Tatar-Yılmaz G, Oruç-Emre EE.
    Bioorg Chem; 2024 Oct 01; 151():107662. PubMed ID: 39079390
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis of some 3-(arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity.
    Küçükgüzel I, Güniz Küçükgüzel S, Rollas S, Otük-Saniş G, Ozdemir O, Bayrak I, Altuğ T, Stables JP.
    Farmaco; 2004 Nov 01; 59(11):893-901. PubMed ID: 15544794
    [Abstract] [Full Text] [Related]

  • 11. Anticonvulsant effect of the hydroethanolic leaf extract of Psydrax subcordata (DC.) Bridson in murine models.
    Daanaa S, Abotsi WKM, Boakye-Gyasi E, Woode E.
    J Ethnopharmacol; 2018 Mar 01; 213():384-394. PubMed ID: 29183747
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
    Grasso S, De Sarro G, De Sarro A, Micale N, Zappalà M, Puia G, Baraldi M, De Micheli C.
    J Med Chem; 1999 Oct 21; 42(21):4414-21. PubMed ID: 10543885
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and anticonvulsant activity evaluation of novel 4-(4-substitutedphenyl)-3-methyl-1H-1,2,4-triazol-5(4H)-ones.
    Zheng Y, Wang SB, Cao X, Liu DC, Shu B, Quan ZS.
    Drug Res (Stuttg); 2014 Jan 21; 64(1):40-6. PubMed ID: 23965799
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and Evaluation of the Anticonvulsant Activities of 4-(2-(Alkylthio)benzo[d]oxazol-5-yl)-2,4-dihydro-3H-1,2,4-triazol-3-ones.
    Song MX, Wang ZY, He SH, Yu SW, Chen SL, Guo DF, Zhao WH, Deng XQ.
    Molecules; 2018 Mar 25; 23(4):. PubMed ID: 29587394
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives.
    Zhang HJ, Jin P, Wang SB, Li FN, Guan LP, Quan ZS.
    Arch Pharm (Weinheim); 2015 Aug 25; 348(8):564-74. PubMed ID: 26053879
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents.
    Dehestani L, Ahangar N, Hashemi SM, Irannejad H, Honarchian Masihi P, Shakiba A, Emami S.
    Bioorg Chem; 2018 Aug 25; 78():119-129. PubMed ID: 29550532
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, receptor affinity and effect on pentylenetetrazole-induced seizure threshold of novel benzodiazepine analogues: 3-Substituted 5-(2-phenoxybenzyl)-4H-1,2,4-triazoles and 2-amino-5-(phenoxybenzyl)-1,3,4-oxadiazoles.
    Mashayekh S, Rahmanipour N, Mahmoodi B, Ahmadi F, Motaharian D, Shahhosseini S, Shafaroodi H, Banafshe HR, Shafiee A, Navidpour L.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1929-37. PubMed ID: 24530225
    [Abstract] [Full Text] [Related]

  • 19. N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.
    Geurts M, Poupaert JH, Scriba GK, Lambert DM.
    J Med Chem; 1998 Jan 01; 41(1):24-30. PubMed ID: 9438018
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted-thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives.
    Gülerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A.
    Farmaco; 1997 Nov 01; 52(11):691-5. PubMed ID: 9550096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.